« Previous
Next »
Forensic Science International
Volume 153, Issue 1
, Pages 29-37
, 4 October 2005
Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid
References
- . Comparative analysis of sweat patches for cocaine (and metabolites) by radioimmunoassay and gas chromatography-positive ion chemical ionization-mass spectrometry. J. Anal. Toxicol. 2004;28(2):86–93
- . Screening postmortem blood and tissues for nine classes [correction of cases] of drugs of abuse using automated microplate immunoassay. Forens. Sci. Int. 1999;106(2):93–102
- . Setting cut-off concentrations for immunoassay screening of postmortem blood. J. Forens. Sci. 1998;43(2):390–394
- . Evaluation of immunochemical drug screenings of whole blood samples A retrospective optimization of cut-off levels after confirmation-analysis on GC–MS and HPLC-DAD. J. Anal. Toxicol. 2003;27(4):205–212
- . Evaluation of the one-step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens. Forens. Sci. Int. 2004;143(2–3):153–156
- . Validation of the Cozart® microplate ELISA for detection of opiates in hair. J. Anal. Toxicol. 2003;27(8):581–586
- . Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart® Opiate Microplate EIA and GC–MS following controlled codeine administration. J. Anal. Toxicol. 2003;27(7):402–407
- . Comparison of daily urine, sweat, and skin swabs among cocaine users. Forens. Sci. Int. 2003;133(1-2):63–78
- . Detection of drugs in saliva of impaired drivers. J. Forens. Sci. 1984;29(1):185–189
- . Use of alternative specimens: drugs of abuse in saliva and doping agents in hair. Ther. Drug Monit. 2002;24(2):239–246
- . Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug Monit. 2004;26(2):200–205
- . Sensitivity and specificity of the Cozart® microplate EIA cocaine oral fluid at proposed screening and confirmation cut-offs. Clin. Chem. 2003;49(9):1498–1503
- . Analysis of drugs of abuse in saliva. Forens. Sci. Rev. 1999;11(1):2–19
- . Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin. Pharmacokinet. 2004;43(3):157–185
- . Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forens. Sci. Int. 2002;128(1/2):90–97
- . On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int. J. Legal Med. 2000;113(3):150–154
- . Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin. Chem. 2001;47(10):1788–1795
- . Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine. J. Anal. Toxicol. 2002;26(7):513–518
- . Comparison of ELISAs for opiates, methamphetamine, cocaine metabolite, benzodiazepines, phencyclidine, and cannabinoids in whole blood and urine. Clin. Chem. 2001;47(3):540–547
- . Use of ELISA for the detection of common drugs of abuse in forensic whole blood samples. Can. Soc. Forens. Sci. J. 1995;28(4):261–269
- Substance Abuse and Mental Health Service Administration. Mandatory guidelines for Federal Workplace Drug Testing Programs. Fed. Regist. 59 (number): 29908–29931 (1994).
PII: S0379-0738(05)00209-4
doi: 10.1016/j.forsciint.2005.04.019
© 2005 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Forensic Science International
Volume 153, Issue 1
, Pages 29-37
, 4 October 2005
